32.jpg)
56.jpg)
USE OF BACTERIA OF THE GENUS TENACIBACULUM FOR QUORUM QUENCHING
Patent number:
US2011195051B, CN102149395B, EP2356991B
No items found.
Use of bacterial cells of the genus Tenacibaculum, from the crude cellular extract or from its cultivation supernatants, capable of degrading N-acyl homoserine lactones, for quorum quenching, for treatment of infectious bacterial illnesses or to inhibit formation of biofilms.
Countries:
Spain
Regions:
Galicia
Centers:
UNIVERSIDAD DE SANTIAGO DE COMPOSTELA
Other entities:
Sectors:
Food & Agro
Health
Subsectors:
Biotechnology
TRL Level:
TRL 4 – technology validated in lab, TRL 5 – technology validated in relevant environment (industrially relevant environment in the case of key enabling technologies)
BRL Level:
PDF Link:
Download hereVideo Link:
Watch it hereSustainable Development Goal:
Applications
Use of this technology to block the processes controlled by AHL-mediated quorum sensing, providing a promising treatment for inhibiting biofilm formation as well as for controlling animal pathogens This represents a cheaper and more sustainable alternative than the use of antibiotics in animals, reducing the costs and occurrence of antibiotic residues and lowering the probability of antibiotic-resistant bacteria.
Comments
Other related patents
Health
Method for predicting the benefit of endocrine therapy in breast cancer
Health
IN VITRO METHOD FOR DETECTING TUMOR GROWTH AND DIAGNOSING OR PROGNOSTICATING THE RISK OF METASTASIS IN A HUMAN SUBJECT THAT HAS BEEN DIAGNOSED WITH UVEAL MELANOMA
Health